Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.5
USERS' SCORE
Good
Based on 12 Reviews
8.1
Supplement Facts
Serving Size: 2 Veg Capsules
Amount Per Serving
%DV
Magnesium (from Magnesium Aspartate)
250 mg
60%
Potassium (from Potassium Aspartate)
99 mg
2%
Taurine (Free-Form)
100 mg
†
Top Medical Research Studies
8
Magnesium scaffold shows promising results
We investigated the clinical safety and performance of a new magnesium scaffold known as DREAMS 3G. This innovative treatment aims to match the effectiveness of drug-eluting stents in coronary interventions.
Over one year, a total of 116 patients were monitored, showing promising results with minimal lumen loss and no adverse events like cardiac death or major thrombosis. Despite a few revascularization interventions, the scaffold appears to be a viable alternative.
Overall, our findings support its potential use in heart treatments.
Over one year, a total of 116 patients were monitored, showing promising results with minimal lumen loss and no adverse events like cardiac death or major thrombosis. Despite a few revascularization interventions, the scaffold appears to be a viable alternative.
Overall, our findings support its potential use in heart treatments.
Read More
9
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
Read More
8
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Read More
Most Useful Reviews
9
Cardiovascular support
4 people found this helpful
Glory to Ukraine! I took this drug for heart treatment and support. I often experience a strong heartbeat, particularly at night. My doctor recommended a magnesium and potassium complex to enhance cardiovascular system functions. The drug has proven to be highly effective in treating cardiovascular dysfunctions.
Read More
9
Effective treatment
3 people found this helpful
Excellent quality! I took this medicine as part of my heart treatment. I frequently experienced a strong heartbeat and increased pulse. My family doctor recommended a magnesium and potassium complex, which has effectively treated my cardiovascular issues.
Read More
7.5
Blood pressure success
2 people found this helpful
I took it for my blood pressure, and I saw positive results. At my health checkup, I had issues with my blood pressure, but after starting this, my levels decreased, and it also lowered my cholesterol and triglycerides.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.5
- All Researches
9
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
Read More
8
We explored whether magnesium intake could influence the risk of retinal vein occlusion (RVO), a leading cause of vision loss. Our analysis involved over 16,000 participants from a national health survey.
We discovered that sufficient magnesium intake was linked to a significant 64% reduced risk of RVO.
This finding was especially relevant for adults under 60, those with hypertension, and individuals without glaucoma. Further studies are needed to confirm magnesium's preventive benefits for RVO.
We discovered that sufficient magnesium intake was linked to a significant 64% reduced risk of RVO.
This finding was especially relevant for adults under 60, those with hypertension, and individuals without glaucoma. Further studies are needed to confirm magnesium's preventive benefits for RVO.
Read More
8
Effective clay-based hemostatic sponge
We examined a new sponge made from clay and collagen to control severe bleeding. Integrating palygorskite clay with collagen using gallic acid created a sponge that resists particle shedding and provides strong adhesion.
In our tests, this sponge demonstrated impressive results, reducing blood loss to 632 mg and achieving hemostasis in just 151 seconds, outperforming traditional gauze and even a well-known product called QuikClot.
With added antibacterial and antioxidant properties, this sponge could significantly enhance emergency bleeding management.
In our tests, this sponge demonstrated impressive results, reducing blood loss to 632 mg and achieving hemostasis in just 151 seconds, outperforming traditional gauze and even a well-known product called QuikClot.
With added antibacterial and antioxidant properties, this sponge could significantly enhance emergency bleeding management.
Read More
8
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Read More
8
Bioresorbable stents' advancements noted
We explored the evolution of bioresorbable metallic stents as alternatives to traditional stents which can lead to complications like thrombosis and inflammation.
While bioresorbable polymeric stents face challenges, materials like zinc and magnesium show promise.
Specifically, magnesium-based stents have demonstrated successful absorption within a year and low rates of complications.
Continuing research will be essential to refine these innovations for better clinical outcomes.
While bioresorbable polymeric stents face challenges, materials like zinc and magnesium show promise.
Specifically, magnesium-based stents have demonstrated successful absorption within a year and low rates of complications.
Continuing research will be essential to refine these innovations for better clinical outcomes.
Read More
User Reviews
USERS' SCORE
Good
Based on 12 Reviews
8.1
- All Reviews
- Positive Reviews
- Negative Reviews
9
Cardiovascular support
4 people found this helpful
Glory to Ukraine! I took this drug for heart treatment and support. I often experience a strong heartbeat, particularly at night. My doctor recommended a magnesium and potassium complex to enhance cardiovascular system functions. The drug has proven to be highly effective in treating cardiovascular dysfunctions.
Read More
9
Effective treatment
3 people found this helpful
Excellent quality! I took this medicine as part of my heart treatment. I frequently experienced a strong heartbeat and increased pulse. My family doctor recommended a magnesium and potassium complex, which has effectively treated my cardiovascular issues.
Read More
7.5
Blood pressure success
2 people found this helpful
I took it for my blood pressure, and I saw positive results. At my health checkup, I had issues with my blood pressure, but after starting this, my levels decreased, and it also lowered my cholesterol and triglycerides.
Read More
9
Significant improvement
1 people found this helpful
My husband began using this after hearing Dr Berg discuss its benefits for reducing high blood pressure. After a few months, his blood pressure has decreased from 148 to 125. This indicates that the supplements are effective, with high-quality ingredients such as aspartate for better absorption. The price and benefits are excellent, and we will purchase again.
Read More
9
Mineral adequacy
NOW Foods, Magnesium & Potassium Aspartate provides essential minerals vital for heart and muscle health. I rated it 5/5 because it supports cardiovascular function and regulates heartbeat and blood pressure effectively. Post-use, I experienced improvements in physical wellbeing, confirming its significance. The quality corresponds to its value.
Read More
Frequently Asked Questions
9
Significant improvement
1 people found this helpful
My husband began using this after hearing Dr Berg discuss its benefits for reducing high blood pressure. After a few months, his blood pressure has decreased from 148 to 125. This indicates that the supplements are effective, with high-quality ingredients such as aspartate for better absorption. The price and benefits are excellent, and we will purchase again.
7.5
Blood pressure success
2 people found this helpful
I took it for my blood pressure, and I saw positive results. At my health checkup, I had issues with my blood pressure, but after starting this, my levels decreased, and it also lowered my cholesterol and triglycerides.
9
Quick blood pressure reduction
6 people found this helpful
Great for quickly lowering blood pressure! I occasionally use this for rapid results, and it’s very effective. With taurine, it’s also beneficial for heart arrhythmias like palpitations. Just be cautious with dosing, as too much might lead to very loose stools.
9
Cardiovascular support
4 people found this helpful
Glory to Ukraine! I took this drug for heart treatment and support. I often experience a strong heartbeat, particularly at night. My doctor recommended a magnesium and potassium complex to enhance cardiovascular system functions. The drug has proven to be highly effective in treating cardiovascular dysfunctions.
9
Effective treatment
3 people found this helpful
Excellent quality! I took this medicine as part of my heart treatment. I frequently experienced a strong heartbeat and increased pulse. My family doctor recommended a magnesium and potassium complex, which has effectively treated my cardiovascular issues.
7.5
Hypertension improvement
3 people found this helpful
I heard that potassium benefits high blood pressure, which my husband has! I'm drinking to relieve swelling. It acts as a diuretic, leading me to frequent visits to the toilet, but it appears to be effective as I'm noticing results. The swelling is reducing, and my hypertension has dropped from 130-140 to 100-110. The bottom number is around 95, so I must be cautious and will continue to drink!
4
Heart rhythm support
12 people found this helpful
This alternative to asparkam has significantly improved my heart health. Magnesium and potassium asparaginate support muscle health and heart function. Together with taurine, they enhance absorption and effectiveness. These two elements are crucial, as potassium needs magnesium for proper uptake. I believe they prevent arrhythmias and aid in blood pressure management while promoting overall heart function.
9
Mineral adequacy
NOW Foods, Magnesium & Potassium Aspartate provides essential minerals vital for heart and muscle health. I rated it 5/5 because it supports cardiovascular function and regulates heartbeat and blood pressure effectively. Post-use, I experienced improvements in physical wellbeing, confirming its significance. The quality corresponds to its value.
8
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
7
Magnesium scaffold safe and effective
We examined the effectiveness of the Magmaris magnesium scaffold on patients with stable coronary artery disease (SCAD) and acute coronary syndrome (ACS) over two years. By looking at data from the Magmaris Multicenter Italian Registry, we found that the rates of target lesion failure and scaffold thrombosis remained low for both groups. Specifically, TLF was 7.4% for SCAD and 8.8% for ACS patients, with scaffold thrombosis observed at 0% and 1.8%, respectively. Overall, the findings suggest that this magnesium scaffold is safe and effective.
8
MAGT1 deficiency increases thrombosis risk
We studied how a lack of magnesium transporter 1 (MAGT1) impacts blood clot formation and the risk of stroke. Using various laboratory and animal models, we observed that MAGT1 deficiency leads to enhanced platelet activity and quicker clotting. This deficiency resulted in faster artery blockage and severe brain damage during strokes. Interestingly, restoring magnesium levels or blocking certain channels helped normalize platelet behavior. Overall, we found that MAGT1's function is crucial for vascular health, indicating its deficiency could elevate risks for thrombosis and ischemic stroke.
References
- Kim J, Kim M, Lee CS, Choi EY. Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis. Nutrients. 2025;17. doi:10.3390/nu17071285
- Guo X, Zeng X, He Y, Zhang X, Shi W, et al. An Antibacterial, Antioxidant Adherent Sponge Constructed for Control of Arterial Bleeding Via Gallic Acid-Mediated Robust Assembly of Fibrous Clay in Collagen. ACS Appl Mater Interfaces. 2025;17:16489. doi:10.1021/acsami.4c19209
- Müller M, Ludwig L, Englert H, Riedl KA, Müller MC, et al. A novel stent flow chamber system demonstrates reduced thrombogenicity of bioresorbable magnesium scaffolds. Sci Rep. 2024;14:26691. doi:10.1038/s41598-024-77266-0
- Zhang J, Chen Z, Rao L, He Y. Coronary bioresorbable metallic stents: Advancements and future perspectives. J Cardiol. 2025;85:69. doi:10.1016/j.jjcc.2024.08.003
- Włodarczak A, Rola P, Włodarczak S, Szudrowicz M, Giniewicz K, et al. Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions. J Pers Med. 2024;14. doi:10.3390/jpm14050540
- Galli S, Troiano S, Palloshi A, Rapetto C, Pisano F, et al. Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry. Cardiovasc Revasc Med. 2023;57:53. doi:10.1016/j.carrev.2023.06.022
- Włodarczak A, Rola P, Barycki M, Furtan Ł, Łanocha M, et al. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds - magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort. Diab Vasc Dis Res. 2023;20:14791641231188705. doi:10.1177/14791641231188705
- Gotru SK, Mammadova-Bach E, Sogkas G, Schuhmann MK, Schmitt K, et al. MAGT1 Deficiency Dysregulates Platelet Cation Homeostasis and Accelerates Arterial Thrombosis and Ischemic Stroke in Mice. Arterioscler Thromb Vasc Biol. 2023;43:1494. doi:10.1161/ATVBAHA.122.318115
- Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, et al. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. EuroIntervention. 2023;19:e414. doi:10.4244/EIJ-D-23-00326
- Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Starmer G, et al. One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry. EuroIntervention. 2023;19:232. doi:10.4244/EIJ-D-22-01069
- Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, et al. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study. EClinicalMedicine. 2023;59:101940. doi:10.1016/j.eclinm.2023.101940
- Pompei G, Campo G, Ruggiero R, Maffeo D, Sgura F, et al. Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study. Int J Cardiol. 2023;383:1. doi:10.1016/j.ijcard.2023.04.029
- Fedele G, Castiglioni S, Maier JAM, Locatelli L. The Effects of Sirolimus and Magnesium on Primary Human Coronary Endothelial Cells: An In Vitro Study. Int J Mol Sci. 2023;24. doi:10.3390/ijms24032930
- Tonai K, Katayama S, Koyama K, Sata N, Tomioka Y, et al. Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study. BMC Anesthesiol. 2022;22:359. doi:10.1186/s12871-022-01903-2
- Seguchi M, Aytekin A, Lenz T, Nicol P, Alvarez-Covarrubias HA, et al. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation. J Cardiol. 2023;81:179. doi:10.1016/j.jjcc.2022.09.003
- Venkatappa MM, Udagani C, Hanumegowda SM, Pramod SN, Venkataramaiah S, et al. Effect of Biofunctional Green Synthesized MgO-Nanoparticles on Oxidative-Stress-Induced Tissue Damage and Thrombosis. Molecules. 2022;27. doi:10.3390/molecules27165162
